Summary Type 1 (insulin-dependent) diabetes mellitus is associated with abnormalities of circulating lymphocyte subsets and autoantibodies. To investigate the prevalence of these in non-diabetic siblings and nondiabetic parents of children with Type 1 diabetes, we analysed T-cell subsets of function and activation in 31 families with an index case of Type 1 diabetes and related these to autoantibodies and HLA DR type. Using two and three colour cytofluorimetry, we studied total and activated (HLA-DR +) CD3 +, CD4 +, CD8 + lymphocytes and on CD4 + lymphocytes the CD45RA/RO "naive" and "memory" cell phenotypes. Diabetic children (mean duration of disease 3.1 years) had a reduced total lymphocyte count (p < 0.05), their non-diabetic siblings a reduced CD4 + T-helper cell count (p < 0.05), and their parents a reduced percentage and number of CD3 + T cells (p < 0.01 and p < 0.05) compared with age-matched control subjects. Diabetic children, their siblings and parents all had significantly increased levels of activated CD4 + T-helper cells (p < 0.01, p < 0.05 and p < 0.01). In diabetic children and their siblings there was a significant over-expression of the CD45RO "memory" cell marker and significant under-expression of the CD45RA "naive" cell marker, whilst these were normal in the parents. Islet cell antibody positive diabetic children had significantly higher levels of CD45RO-expressing CD4 + lymphocytes than those who were islet cell antibody negative (p < 0.05). Amongst the siblings and parents, possession of HLA-DR4 was associated with lower percentages of CD4 + and higher percentages of CD8 + T cells. These findings extend current knowledge about the role of immunoregulatory CD45RA/ RO cells in Type 1 diabetes. In addition, they demonstrate lymphocyte subset abnormalities in unaffected family members, some of which may be influenced by HLA DR alleles. [Diabetologia (1994) 37:155-165] Key words T-cell activation, T-cell memory, CD45 isoforms, HLA DR types, first degree relatives of diabetic patients.
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Type 1 (insulin-dependent) diabetes mellitus results from the destruction of islet beta cells in the pancreas, and the finding of a T-lymphocyte infiltrate in the islets both at diagnosis [1] of the disease and following recurrent diabetes in pancreatic iso-grafts [2] supports the contention that the disease is immune-mediated [3] . Further evidence of a role for the immune system in 
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Corresponding author: Dr. M. Peakman, Department of Immunology, King's College School of Medicine and Dentistry, London 5E5 9PJ, UK beta-cell damage derives from the finding at diagnosis of autoantibodies [4] and alterations in lymphocyte subsets in the peripheral blood, including elevated levels of activated T cells [5] , CD5 + B lymphocytes [6] and CD45RA + ("naive") CD4 + and CD8 + lymphocytes [7, 8] .
There is a strong genetic component in susceptibility to the development of Type 1 diabetes, a large proportion of which maps to the MHC class II region on chromosome 6 [9] . The protein products of this region, the heterodimeric surface molecules HLA-DR, -DP and -DQ, present peptide antigens to T lymphocytes. One explanation of their role in susceptibility to diabetes is that class II molecules have a critical role in presenting beta-cell autoantigens to autoreactive T lymphocytes in the islets of Langerhans. Arguing against this mechanism is the fact that the highest risk of Type 1 diabetes is associated with alleles at the DO locus [10, 11] , yet the vast majority of autoreactive T-cell clones generated from patients with autoimmune diseases such as Type 1 diabetes are restricted to autoantigens presented not by HLA-DQ molecules, but by HLA-DR [12] [13] [14] . For this reason, alternative explanations for HLA-associated susceptibility are being sought [15] . One possibility is that class II alleles, originally known as the "immune response" genes, influence the reactivity of individuals to an immune stimulus.
To characterise cellular and humoral immune abnormalities in first degree relatives of Type 1 diabetic children, we studied lymphocyte subsets of function and activation in families with an index case of Type 1 diabetes. In addition, families were HLA typed, to examine whether cellular immune abnormalities segregate with particular HLA DR alleles.
Subjects, materials and methods
We studied 31 families, all with a single index case of Type 1 diabetes attending the District Diabetes Centre, Farnborough Hospital, Kent. All families with children attending the Diabetes Centre were approached and all those willing to participate were recruited. Ethical permission for this study was obtained from the Farnborough Hospital Ethical Committee and all participants gave their informed consent. In 8 families, samples were obtained from both parents and 2 siblings; in 12 families from both parents and one sibling; in 4 families from both parents only; in the remainder, samples were obtained from the mother and 3 siblings (n = 1), 2 siblings (n = 1), one sibling (n = 1) or no siblings (n = 3); in one family, samples were obtained from the father and index case only.
There were a total of 31 children with Type 1 diabetes (14 males, mean age ± SD; 10.8 ± 4.5 years) with a mean duration of diabetes of 3.1 ± 1.5 years. Duration of diabetes ranged from 3 months to 5 years, and 3 diabetic children were studied within 1 year of diagnosis. Type 1 diabetes was defined in accordance with the guidelines of the National Diabetes Data Group [16] requiring insulin to prevent diabetic ketoacidosis and sustain life, and at diagnosis, all had elevated blood glucose and glycosuria. At the time of sampling, mean random blood glucose level amongst the diabetic children was 11.9 ± 5.5 mmol/1 and the mean level of haemoglobin A l° (HbA tc ) amongst the diabetic children was 10.1 ± 1.8 %. In addition, we studied 55 parents, (25 males, age 39.1 ± 7.0 years) and 34 siblings (15 males, mean age 12.8 ± 4.3 years), none of whom had diabetes (mean ± SD level of HbA 1 , 6.8 % ± 0.7 in the siblings and 6.7 % ± 0.7 in the parents). As control subjects, blood was obtained from 25 healthy adults (11 males, age 35.4 ± 6.6 years) recruited from the staff of King's College Hospital and 25 healthy children (12 males, age 11.4 ± 3.8 years) who were recruited by the Medway and Gillingham Branch (Kent) of the Children's Liver Disease Foundation (CHILD). None of the control subjects had a family history of Type 1 diabetes. Blood was drawn from control subjects during the same period and at the same time of day as for the study group to avoid biases resulting from seasonal, diurnal, or technical variations. Samples were only obtained from individuals without symptoms or clinical evidence of infection.
Blood was taken into bactericidal-free heparin (10 U/ml), 10 mmol/l EDTA or allowed to clot at room temperature for 30 min. Serum was separated from clotted blood by centrifugation at 1500 g, aliquoted and stored -70°C.
Lysed whole blood immunofluorescence staining of lymphocytes
To restrict the effects of day-to-day variability on the measurement of lymphocyte subsets, the majority of the study group (26 of 31 families) and all subjects in the control groups were bled en masse and the analyses performed on four single days. Lymphocyte subsets were identified by two and three colour immunofluorescence staining using a lysed whole blood technique as previously described [7, 17, 18] . The monoclonal antibody combinations used and the populations identified are shown in Table 1 . Analysis of stained lymphocytes was carried out using an aircooled, single argon laser, bench-top flow cytometer (FACScan; Becton Dickinson, Oxford, UK). Data were acquired on between 5,000 and 10,000 cells and stored in list mode. Fluorescence data were acquired in logarithmic mode over five log decades. Non-specific binding of monoclonal antibodies was assessed using isotype-and fluorochrome-matched monoclonal antibodies directed against an irrelevant target (anti-keyhole limpet haemocyanin, Becton Dickinson) and was subtracted from all results. All data acquisition and analysis was performed by a single operator unaware of the source of the samples. Inter-and intra-assay coefficients of variation established using 10 consecutive determinations on a single day and on a cryopreserved sample of peripheral blood mononuclear cells over several days were less than 6% and less than 10%, respectively.
Total (CD3 + ) T lymphocytes are expressed as a percentage of the total lymphocytes; CD4 + and CD8 + T lymphocytes as a percentage of total T cells; activated cells as a percentage of the CD3 +, CD4 + and CD8 + populations; CD45R subsets as a percentage of the CD4 + population; TCRy8 + T lymphocytes as a percentage of the CD3 + T-lymphocyte population; and CD5 + B lymphocytes as a percentage of the CD20 + B-cell population. Absolute numbers of lymphocyte subsets were derived from leucocyte counts and lymphocyte differentials performed on a Coulter Stacker (Coulter, Hialeah, Fla., USA).
HLA typing
Class II HLA DR typing was carried using restriction fragment length polymorphism (RFLP) analysis as previously described [19] . HLA-DRB gene polymorphisms were identified using a 517bp PStI fragment of the exon-specific HLA-DRB cDNA clone pRTvl (kindly supplied by Dr. J. Bidwell, UK Transplant Centre, Bristol, UK). HLA-DRB allogenotypes were identified from the hybridization patterns visualised by autoradiography [20] [21] [22] .
Detection of autoantibodies
Islet cell cytoplasmic antibodies (ICA) were detected in a twostep indirect immunofluorescence assay as previously described [23] on unfixed 5-µm cryostat sections of blood group 0 human pancreas. This assay was tested in the stage III Immunology and Diabetes Workshop in ICA proficiency, performing with 100 % specificity, a detection limit of 5 Juvenile Diabetes Foundation Non-organ-specific autoantibodies (anti-nuclear (ANA), antismooth muscle (SMA), anti-gastric parietal cell (GPC), anti-mitochondrial (AMA) and anti-reticulin (ARA) antibodies) were detected by a similar technique using rat liver, kidney and stomach as substrate [24] . Autoantibodies reacting with thyroid microsomal antigens and with thyroglobulin were detected by particle agglutination using commerically available kits (Serodia-ATG, Serodia-ACM; Fujirebio, Tokyo, Japan).
Statistical analysis
Lymphocyte subsets were normally distributed according to the Kolmogorov-Smirnov goodness of fit test and mean values were compared using a one way analysis of variance and Student's ttests. Results were considered significant if p was less than 0.05. In view of the smaller numbers and large variances, comparisons of variables between groups divided according to the presence or absence of autoantibodies and HLA DR types were performed using the non-parametric Mann-Whitney U-test. Comparison of the frequencies of autoantibodies occurring with different HLA alleles was performed using the Fisher's exact prob-ability test. Correlations between variables were analysed by calculating Pearson's correlation coefficient or performing Spearman's rank correlation tests as appropriate. Statistical computations were performed using the Statistical Package for the Social Sciences on the University of London Computer Centre's Amdahl 5980/300.
Results

Total, CD3 +, CD4 + and CD8 + lymphocyte subsets
The mean concentration of total lymphocytes was significantly reduced in children with Type 1 diabetes compared with control subjects (p < 0.05; Table 2 ). Nondiabetic siblings had levels of total lymphocytes similar to the mean concentration in the diabetic children but not significantly different from control subjects. The mean concentration of total lymphocytes in the parents was similar to that of the adult control group. The percentage and absolute number of CD3 + T lymphocytes were significantly lower in parents of children with Type 1 diabetes compared with control subjects (p < 0.01 and p < 0.05, respectively), but normal in the diabetic children and their siblings.
Percentages of CD4 + T lymphocytes were similar in all study groups compared with control subjects. The absolute number of circulating CD4 + T lymphocytes was significantly lower in the siblings (p < 0.05) when compared with the appropriate control subjects. Percentages and absolute numbers of CD8 + lymphocytes were similar in all study groups compared with the appropriate control subjects. The CD4: CD8 ratio was not significantly different in diabetic children and their siblings compared with control subjects. The CD4: CD8 ratio was significantly reduced in the parents compared with control subjects (p < 0.05).
Total, CD3 + , CD4 + and CD8 + lymphocyte populations were similar in the diabetic children and their siblings.
HLA-DR expression on CD3 +, CD4 + and CD8 + T lymphocytes
Levels of activated (HLA-DR +) CD3 + T lymphocytes were significantly elevated in the group of siblings compared with control subjects (p < 0.05) ( Table 2) . Mean levels of activated T lymphocytes in children with Type 1 diabetes and their parents were not significantly different from those of the appropriate control group.
The percentage of CD4 + T lymphocytes which was HLA-DR + was significantly higher in the diabetic children (p < 0.01), their siblings (p < 0.05) and their parents (p < 0.01) compared with the control subjects. The percentage of CD8 + T lymphocytes which was activated was similar in the diabetic children and their siblings compared with the control subjects. Activated CD3 + , CD4 + and CD8 + lymphocytes were similar in the diabetic children and their siblings.
CD45RA and CD45RO expression and CD4 + T lymphocytes
Expression of the CD45R isoforms RA and RO can be divided into three groupings. Firstly, a CD45R isoform may occur alone on a cell (i. e. CD45RA + ROand CD45RA-RO + cells). Secondly, double-positive, CD45RA + RO + cells may be detected, representing a transition state from expression of one isoform to the other. Finally, CD45R isoform expression may be represented by the total CD45RA + (CD45RA + RO-plus CD45RA + RO +) and total CD45RO + (CD45RA-RO + plus CD45RA + RO +) cells.
In analysing these results a clear pattern of abnormal distribution of CD45 isoforms in diabetic children and their siblings was apparent, in favour of a relative over-expression of CD45RO and under-expression of CD45RA.
Levels of CD45RA + RO-CD4 + T lymphocytes were significantly reduced in the diabetic children and their siblings compared with control subjects (p < 0.01 for both) ( Table 3 ). In contrast, levels of CD45RA-RO + CD4 + lymphocytes were significantly elevated in diabetic children and their siblings compared with control subjects (p < 0.01 for both). Levels of CD45RA + RO + CD4 + lymphocytes were similar in diabetic children, siblings and control subjects. As a result, total CD45RA + CD4 + lymphocytes were significantly lower and total CD45RO + CD4 + lymphocytes significantly higher in diabetic children (p < 0.01 and p < 0.05, respectively) and their siblings (p < 0.001 and p < 0.01, respectively) compared with the control subjects. These findings are reflected in the ratio of CD45RA : RO amongst the CD4 + lymphocyte population, which was significantly reduced in diabetic children and their siblings compared with control subjects (p < 0.05 and p < 0.01, respectively). Amongst the siblings, there was no evidence of clustering of low or high levels of cells expressing particular CD45R isoforms in individual families. In the healthy children, levels of CD45RA + RO-CD4 + lymphocytes declined with age (r = -0.54, p < 0.01), but no relationship between age and CD45R subsets was seen in the study groups.
Levels of CD45 subsets and the CD45RA : RO ratio amongst CD4 + lymphocytes were similar in the diabetic children and their siblings and were similar in the parents of the diabetic children compared with the control group. 
TCR-yb+ T lymphocytes and CD5 + B lymphocytes
Levels of TCR-yS+ T lymphocytes were not significantly different in diabetic children (mean ± SD; 5.7 ± 2.5 %) or their siblings (6.0±3.4%) compared with the normal children (6.5 ± 2.5 %), nor in their parents (4.4 ± 2.8 %) w1, --n compared with the adult control group (4.3 ± 4.1 %). Levels of CD5 + B lymphocytes were not significantly different in diabetic children (mean ± SD; 36.9 ± 1<<.9 %) or their siblings (31.2 ± 14.1 %) compared with the normal children (30.4 ± 11.2 %), nor in their parents (19.5 ± 14.1 %) when compared with the adult control group (23.2 ± 14.3 %).
Associations between lymphocyte subsets and islet cell antibodies
Islet cell antibodies (ICA) were detected in 17 diabetic children (55%), 4 (12%) of the siblings and 2 (4 %) of the parents. Levels of total and activated CD3 +, Siblings who were ICA positive had similar levels of the CD45RA : RO ratio compared with those who were ICA negative.
Associations between lymphocyte subsets and other autoantibodies
Autoantibodies other than ICA were detected in 6 diabetic children (19%), 8 siblings (24%) and 15 parents (29%). In one diabetic child, four siblings and six parents more than one autoantibody was present, usually as a combination of gastric parietal cell antibody and thyroid microsomal antibody which accounted for six of the cases of multiple autoantibodies.
Levels of total and activated CD3 +, CD4 + and CD8 + T cell subsets, TCR-y8 + T cells and CD45RA/ CD45RO subsets of CD4 + lymphocytes were similar in groups of diabetic children divided according to the presence or absence of one or more of the non-ICA autoantibodies.
In contrast, when siblings were divided according to the presence or absence of all non-ICA autoantibodies, level of HLA-DR + CD3 + T lymphocytes were significantly lower in the autoantibody-positive group (median (range); 5.2% (3.5-8.1) vs 7.5% (3.5-16.8); Table 1 ) p < 0.05), whilst other T-lymphocyte subsets were similar in the two groups.
In the parents, percentage levels of CD8 + lymphocytes were significantly lower in the autoantibody-positive group (30.8 % (23.1-54.7)) compared with those who were autoantibody negative (38.1 % (30.5-66.0); p < 0.05). In addition, a significantly lower percentage of CD5 + B lymphocytes was found in autoantibodypositive parents, compared with those without circulating autoantibodies (11.6 (6.6-25.0) vs 17.1 (6.4-73.3); p < 0.05). Other lymphocyte subsets were similar in parents divided into groups according to the presence or absence of non-ICA autoantibodies.
Associations betweeen lymphocyte subsets and HLA DR types
In previous studies it has been shown that approximately 90 % of children with Type 1 diabetes possess at least one DR3 or DR4 allele, and it is likely that any influence of class II loci on immune function in this disease would operate through these two genes. For this reason, and because of the small numbers in each study group, individuals were assigned to the following four groups: (i) possession of homozygous DR 3/3 or heterozygous DR3/X; (ii) heterozygous DR 3/4; (iii) homozygous DR 4/4 or heterozygous DR4/X; and (iv) DRX/X (where X is neither DR3 nor DR4).
Amongst the diabetic children, 7 (23 %) were DR3/3 or DR3/X, 13 (42 %) were DR3/4, 9(29%) were DR4/4 or DR4/X and 2 (6%) were DRX/X so that 94 % of the diabetic children possessed at least one DR3 or DR4 allele. Amongst the siblings, 12 (35 %) were DR3/3 or DR3/X, 6 (18%) were DR3/4, 6 (18%) were DR4/4 or DR4/X, and 10 (29%) were DRXIX. The frequency of certain haplotypes was different in the diabetic children compared with the siblings. A significantly higher proportion of the diabetic children were DR3/4 heterozygous (Fisher's exact probability p = 0.029), whilst significantly more of the siblings possessed alleles other than DR3 or DR4 (DRXIX; Fisher's exact probabilityp = 0.018).
Amongst the diabetic children, there were no significant differences in levels of lymphocyte subsets between the four groups of class II haplotypes defined above.
Siblings with DR4/4 or DR4/X had significantly lower percentage levels of CD4 + lymphocytes and significantly higher percentage levels of CD8 + lymphocytes compared with those possessing DR3/3 or DR3/X and compared with control subjects (Table 4) . This reduction of CD4 + lymphocytes and increase in CD8 + lymphocytes could not be attributed to clustering of low and high levels, respectively, in a small number of families, as shown by the individual values in Figure 1 .
Three of the parents were not HLA typed. Of the remainder, 18 (35 %) were DR3/3 homozygous or DR3/X, 12 (23 %) were DR3/4 heterozygous, 12 (23 %) were DR4/4 or DR4/X and 10 (18%) were DRX/X. The abnormality seen in the siblings was also seen in the parents (Table 4) . Parents with DR4/4 or DR4/X had significantly lower percentage levels of CD4 + lymphocytes and significantly higher percentages of CD8 + lymphocytes compared with those with DR3/3 or DR3/X and compared with control subjects. In addition, levels of CD4 + lymphocytes were also significantly lower in DR4/4 and DR4/X parents and levels of CD8 + lymphocytes significantly higher compared with parents who were DR3/4 heterozygotes (% CD4, 60.1 % (48.1-73.1); % CD8, 36.2 % (26.3-46.5); p < 0.05 for both), suggesting that the DR3 allele has the strongest influence on determining high levels of CD4 + and low levels of CD8 + lymphocytes. Again, the DR4-associated reduction in CD4 + lymphocytes and increase in CD8 + lymphocytes could not be attributed to clustering of low and high levels, respectively, in a small number of families, as shown by the individual values in Figure 1 .
To examine a possible genetic influence on CD4: CD8 ratio more closely, evidence of co-segregation of a low ratio with DR types was sought. In % CD4 lymphocytes and CD8 + T lymphocytes (bottom panel) in siblings (triangles) and parents (circles) in 26 individual families with an index case of Type 1 diabetes in whom data on first degree relatives was available. Individuals carrying HLA-DR4 are represented by filled triangles and circles 11 families, ratios lower than the control mean in siblings segregated with a maternal or paternal haplotype, but no particular DR type was identified. Equally, no consistent pattern of alteration in CD4: CD8 ratio was shared by haploidentical siblings. There was no evidence that siblings with the heterozygous HLA DR3/4 type or those sharing HLA identity with the index case had altered CD45RA : RO ratios in comparison with the remaining siblings.
Association between lymphocyte subsets, metabolic control and duration of diabetes
Amongst the diabetic children there was no relationship between the major functional T-cell subsets, CD45R subsets of CD4 + T lymphocytes or CD5 + B cells and random blood glucose, HbA,,, or duration of diabetes. A positive correlation between the percentage of HLA-DR + CD3 + T lymphocytes, the percentage of HLA-DR + CD8 T lymphocytes and level of HbA,c was seen (r = 0.43 and r = 0.42, respectively; p < 0.05).
To further examine the influence of metabolic control on lymphocyte subsets, children with Type 1 diabetes were divided into those with HbA 1C levels less than 10.0 and those more than 10.0%, with 15 and 16 children in each group, respectively. Compared with control subjects, diabetic children with worse metabolic control had significantly reduced total lymphocyte concentrations (mean ± SD; 2.4 ± 0.6 x 106/ml, p < 0.01), whilst these were normal in the children with better control. Percentage levels of CD4 + HLA-DR + T cells were significantly elevated in both groups of diabetic children (p < 0.01 for both), indicating that this abnormality is not influenced by glycaemic control. As one might expect from the correlation between CD8 + HLA-DR + T cells and HbA I ,, significantly reduced levels of these cells were found in the better controlled diabetic children compared with control subjects (9.1 ± 4.5 %, p < 0.01) but normal levels in the patients with HbA lc greater than 10.0%. None of the other immune parameters behaved differently in the two groups of diabetic children compared with the control subjects.
Associations between autoantibodies and HLA DR types
The presence of the auto antibodies ICA, ANA, SMA, ARA and AMA, GPC, TMA and TGA, analysed individually or as groups of non-organ and organ-specific autoantibodies, was not associated with any particular HLA DR type in diabetic children or their siblings. The same was true for their parents, with the exception of autoantibodies to thyroid microsomes or thyroglobulin, or both which were more frequently found in individuals with the haplotype DR3/3 or 3/X (40 %) than in those with DR4/4 or 4/X (0%; p = 0.04).
Discussion
We have shown that abnormalities of lymphocyte phenotypic markers of function and activation are present in non-diabetic first degree relatives of children with Type 1 diabetes, as well as in the diabetic children themselves. The absolute number of CD4 + lymphocytes was significantly reduced in siblings of diabetic children. Levels of activated T lymphocytes were elevated in siblings and there was an increase in activated CD4 + T lymphocytes in all family members. Over-expression of the memory-cell marker CD45RO and a reciprocal reduction in expression of the CD45RA marker of naive cells was detected in both diabetic children and their siblings, and amongst the former, was more marked in those with ICA. Finally, possession of HLA-DR4 appears to influence peripheral blood lymphocytes, since its presence was associated with reduced percentages of CD4 + and increased percentages of CD8 + cells in both siblings and parents of diabetic children.
There have been few previous studies of lymphocyte subsets in children with diabetes of several years duration. Results obtained in the present study for the main CD3 +, CD4 + and CD8 + populations are similar to those of Pontesilli et al. [25] who also used a lysed whole blood technique and found a mild lymphopaenia and reduced percentages of CD3 + and CD4 + lymphocytes, but also low levels of CD8 + lymphocytes. Studying twins with diabetes of several years duration, Johnston et al. [26] found reduced levels of total T and CD4 + lymphocytes, as well as reduced CD8 + lymphocytes, as did Galluzzo et al. [27] and Quiniou-Debrie et al. [28] . The finding of reduced CD8 + lymphocytes in these studies but not our own may reflect a different approach to quantifying CD8 + cells, which in this study were simultaneously identified as T lymphocytes by double staining with antibodies to CD3. Staining with a single antibody, as in the other studies cited, would include the sizeable proportion of CD8 + lymphocytes which do not express CD3 [29] , and this may be the population which is altered in diabetes.
Our data indicate reduced levels of absolute numbers of CD4 + lymphocytes in the siblings of diabetic children, and a reduced CD4: CD8 ratio in the siblings and parents, suggesting an inherited abnormality. Some evidence to support this derives from analysis of the HLA DR types, which identifies an association between possession of the HLA-DR4 allele and low percentage levels of CD4 + and reciprocally high levels of CD8 + lymphocytes in siblings and parents, compared with non-DR4 siblings and with control subjects. Evidence of co-segregation of low CD4: CD8 ratio and particular HLA-DR types was not found, possibly due to the relatively small number of families studied. DR3/4 heterozygotes had levels of CD4 + and CD8 + T lymphocytes similar to siblings and parents with DR3 alone, suggesting that possession of DR3 can outweigh the influence of DR4 on these T-cell subsets. The presence of individuals possessing HLA DR4 could thus account for the low levels of CD4 + lymphocytes seen in these study groups. The numbers of diabetic children, siblings and parents with DR4 are small, however, and such a finding requires confirmation in a larger group. In addition, our data do not demonstrate whether or not the association is confined to families with an index case of diabetes or applies to DR4 in the general population, since our control subjects were not HLA typed. It is of interest that the association between the imbalance in CD4 + and CD8 + lymphocytes and possession of HLA-DR4 was not seen in the diabetic children. Since the mean duration of diabetes was more than 3 years and all children were treated with insulin it is possible that chronic hyperglycaemia or exogenous insulin, both of which are known to be capable of affecting immune function [30, 31] , have exerted an effect in elevating CD4 + and depressing CD8 + lymphocyte levels in these patients partially overriding the effects seen in the siblings and parents.
Elevated levels of activated (HLA-DR +) T lymphocytes are a consistent finding in studies of patients with Type 1 diabetes near to the time of diagnosis [5, [32] [33] [34] . Levels begin to decline 6 months after diagnosis, and are normal in patients with long-term disease, unless diabetic complications are present [35, 36] . Levels of activated total CD3 + T lymphocytes were normal in the children with Type 1 diabetes in the present study, yet the proportion of CD4 + T lymphocytes expressing HLA-DR was significantly elevated. This suggests that immune activation in Type 1 diabetes is ongoing, but is largely confined to the CD4 + subset and may not be revealed by analysis of total T lymphocytes. Elevated levels of activated total T cells were found in the siblings, and an increased proportion of CD4 + lymphocytes which were activated were detected in siblings and parents. Siblings of children with Type 1 diabetes, despite often sharing the environmental and genetic risk of diabetes with the diabetic members of their family, have a relatively low risk of developing the disease themselves [37] . Activated T lymphocytes in siblings in this study are therefore unlikely to represent impending diabetes. The presence of a high proportion of activated CD4 + lymphocytes in siblings, parents and the diabetic children may represent the presence of a hyperactive immune system. Such a state has been previously invoked as a possible predisposing factor to autoimmune diseases in individuals with the haplotype Al B8 DR3, who have impaired Fc receptor function [38] and impaired suppressor-cell function [39] . This hypothesis proposes that on this background, an environmental stimulus, such as a virus infection, could invoke an inappropriately vigorous immune response, in which damage to other host tissues is also incurred.
In a previous study, we described an over-representation of CD45RO on CD4 + lymphocytes in patients with long-term Type 1 diabetes, a finding confirmed in the present study [7] . The cell surface antigen CD45 has several isoforms and the presence of two of these phenotypes, CD45RA and CD45RO, appears to have a direct bearing upon the functional properties of the lymphocytes expressing them. CD45RA + ROcells are "virgin", or immunologically naive cells present at high levels in the fetus [40] , and which, upon stimulation, begin to acquire the CD45RO marker of "primed" or memory cells [41] . Functionally, naive cells are unresponsive to antigenic stimulation and suppress other lymphocyte responses, whilst memory cells make appropriate proliferative responses and promote other lymphocyte responses such as antibody production by B lymphocytes. Several studies of the RA and RO isoforms of CD45 have been performed in chronic autoimmune diseases, indicating an expansion of the CD45RO subset of CD4 + lymphocytes in multiple sclerosis [42] and systemic lupus erythematosus [43] . In contrast, in patients analysed soon after the onset of Type 1 diabetes a relative over-expression of CD45RA is found [7, 44] . Our present findings are consistent with both diabetic children and unaffected siblings being exposed to environmental stimuli which results in changes in immunoregulatory lymphocytes. Siblings who do not become diabetic are characterised by a preponderance of CD45RO lymphocytes in comparison with healthy children and are thus immunologically "primed". These results are in keeping with those of Schatz et al. [45] , who found that levels of memory cells were higher and naive cells lower in a group of subjects including low-risk, ICA-negative first degree relatives. Faustman et al. [46] investigated low-risk first degree relatives and failed to detect these abnormalities, but in their study memory cells were identified using antibodies directed against CDw29, which is known to be less powerful at discriminating this population than CD45RO [47] . Whether or not the primed immune system is protective against the development of diabetes is not known, but this possibility is supported by studies in the non-obese diabetic mouse and BB rat animal models of Type 1 diabetes, in which mice delivered by Caesarean section and reared in pathogen-free environments have a higher incidence of diabetes than those reared unprotected [48, 49] . Alternatively, the presence of an excess of primed CD45RO + lymphocytes could be the result of an appropriate immune response to environmental agents involved in the aetiology of Type 1 diabetes.
In summary, we describe abnormalities of immunoregulatory lymphocyte subsets and activated helper T cells in first degree relatives of children with Type 1 diabetes. Some of the differences between the study groups and control subjects are small, and will require confirmation in larger studies. The finding, however, that similar patterns of abnormality are frequently present in diabetic children, siblings and parents supports our conclusions. Some of the abnormalities of lymphocyte subsets may be influenced by the HLA system, and could represent one component of the susceptibility conferred by inheritance of particular alleles. In addition, we extend our understanding of the relationship of CD45 isoforms to autoimmune disease, and suggest that primed lymphocytes could provide protection from Type 1 diabetes.
